期刊文献+

甲状腺髓样癌的临床病理分析

Clinicopathology of Medullary Thyroid Carcinoma
下载PDF
导出
摘要 目的探讨甲状腺髓样癌的临床病理特征。方法对16例经免疫组织化学证实为甲状腺髓样癌病例的临床、病理、免疫组织化学染色特征进行回顾性分析。结果甲状腺髓样癌多表现为结节状肿块,镜下形态表现复杂多样,癌样、肉瘤样均可,背景中常有淀粉样物质沉积。免疫组织化学:Ckpan(+)7例(43.75%),EMA(+)6例(37.5%),Vim(+)1例(6.25%),TG(-)16例(100.0%),CT(+)15例(93.75%),Syn(+)9例(56.25%),CgA(+)7例(43.75%),CEA(+)5例(31.25%),刚果红染色(+)14例(87.5%)。结论甲状腺髓样癌是一种形态多样化并伴有神经内分泌特征的侵袭性恶性肿瘤,其诊断依赖于组织形态及免疫组织化学染色特征。 Objective To investigate the clinicopathological features of medullary thyroid carcinoma.Methods The clinical,pathological and immunohistochemical characteristics of 16 cases of immunohistochemically proven medullary thyroid carcinoma were retrospectively analyzed.ResultsMedullary thyroid carcinoma had cancer like and sarcomatoid features,with the appearance of nodular mass and amyloid deposition.Of the 16 cases,immunohistochemistry showed Ckpan(+)in 7(43.75%),EMA(+) in 6(37.5%),Vim(+) in 1(6.25%),TG(-)in 16(100.0%),CT(+) in 15(93.75%),Syn(+)in 9(56.25%),CgA(+)in 7(43.75%),CEA(+)in 5(31.25%),and Congored staining(+)in 14(87.5%).Conclusion Medullary thyroid carcinoma is a malignant tumor with morphological diversity and neuroendocrine characters,and its diagnosis depends on morphology and immunohistochemistry.
作者 王晨亮
出处 《南昌大学学报(医学版)》 CAS 2011年第5期48-50,F0003,共4页 Journal of Nanchang University:Medical Sciences
关键词 甲状腺髓样癌 临床病理 诊断 medullary thyroid carcinoma clinicopathology diagnostic
  • 相关文献

参考文献9

  • 1于洋,高明.甲状腺髓样癌研究进展[J].现代肿瘤医学,2008,16(7):1242-1244. 被引量:11
  • 2[美]J·罗萨伊(Juan Rosai) 著,回允中 主.阿克曼外科病理学[M]辽宁教育出版社,1999.
  • 3Huang Cai-ping,,Zhou Yong-yue,Shi Da-ren,et al.Relationshipbetween expression of CD44V6 in medullary thyoid carcinomaand its cervical lymph node metastasis. J Fudan Univ(MedSci) . 2001
  • 4Ringel M,Kloos R T,Arbogast D,et al.PhaseⅡstudy of oralhistone deacetylase inhibitor in patients with metastatic thyroidcancer. The 77th Annual Meeting of the AmericaThyroid Association . 2006
  • 5Hofstra RM,Fattoruso O,Quadro L,et al.A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma. The Journal of Clinical Endocrinology . 1997
  • 6Santoro,M,Rosati,R,Grieco,M,Berlingieri,MT,Colucci D’Amato,GL,De,Franciscis,V.The RET proto-oncogene is consistently expressed in human pheochromocytoma and thyroid medullary carcinomas. Oncegene . 1990
  • 7Evans,DB,Fleming,JB,Lee,JE.The surgical treatment of medullary thyroid carcinoma. Seminars in Surgical Oncology . 1999
  • 8Cohen MS,Moley JF.Surgical treatment of medullary thyroid carcinoma. Journal of Internal Medicine . 2003
  • 9Morabito A,Piccirillo MC,Falasconi F,et al.Vandetanib (ZD6474),a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases:Current Status and Future Directions. The Oncologist . 2009

二级参考文献3

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部